Cipla stock rises nearly 2% after USFDA grants VAI status to Goa plant
Shares of Cipla gained nearly 2 per cent on Monday, following the United States Food and Drug Administration (USFDA) classifying
Continue readingThe Number One Finance & Business Blog!
Shares of Cipla gained nearly 2 per cent on Monday, following the United States Food and Drug Administration (USFDA) classifying
Continue reading